Clinical Trials Logo

Hyperphosphataemia clinical trials

View clinical trials related to Hyperphosphataemia.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02151643 Completed - Hyperphosphataemia Clinical Trials

Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease

Start date: May 7, 2014
Phase: Phase 2
Study type: Interventional

The main purpose of this study is to see whether PT20 can help people with a high level of phosphate in their blood (called Hyperphosphatemia) that are being treated with dialysis for kidney disease.

NCT ID: NCT01857024 Completed - Clinical trials for Chronic Kidney Disease

Post Authorisation Safety Study of Renvela® in Chronic Kidney Disease Patients Not on Dialysis With Hyperphosphataemia

Start date: September 2010
Phase: N/A
Study type: Observational

The primary objective of this study is to assess in a post-approval clinical setting the safety profile of sevelamer carbonate (Renvela®) tablets and powder in adult hyperphosphataemic chronic kidney disease (CKD) patients not on dialysis with serum phosphorus ≥1.78 mmol/L. Patients will be treated in accordance with the Renvela® Summary of Product Characteristics (SmPC) and followed according to the investigator's standard clinical practice management. Each patient will be followed up for 12 months or up to the time they start dialysis, whichever occurs first.

NCT ID: NCT01424787 Completed - ESRD Clinical Trials

Non-interventional Study to Evaluate the Ease of Reaching Individual Goals in Serum Phosphorus (Steering)

Steering
Start date: October 2011
Phase: N/A
Study type: Observational

The objective of this non-interventional study is to confirm that with standard OsvaRen® treatment it is possible to achieve in at least 60% of the patients the levels of phosphorus, total calcium, and iPTH seen in the CALMAG study also in the normal clinical practice.